In a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc. (NYSE:PFE) has agreed to ...
Pfizer has agreed to settle more than 10,000 lawsuits which alleged that the company failed to warn patients about possible cancer risks caused by the anti-heartburn medication Zantac. The ...
Pfizer has agreed to pay up to $250mn to settle more than 10,000 US lawsuits over cancer risks associated with its now-discontinued heartburn drug Zantac, according to people familiar with the deal.
Pfizer will pay up to $250 million to settle more than 10,000 U.S. lawsuits over cancer risks associated with its ...
Pharmaceutical giant Pfizer has settled over 10,000 lawsuits accusing the company of concealing cancer risks associated with its antacid medication, Zantac. The lawsuits, filed in courts across the ...
Zantac. According to a Bloomberg report, Pfizer has agreed to settle over 10,000 lawsuits that accused the company of concealing the cancer risks associated with Zantac. This settlement marks the ...
Pfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn drug, according to people familiar with the deal, the biggest of the litigation.
Pfizer (PFE), which sold Zantac between 1998 and 2006, said it continues to “vigorously defend against Zantac lawsuits, which it believes are not supported by reliable science”, the report noted.
Pfizer has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn drug, according to people familiar with the deal, the biggest of the litigation.
Pfizer shares were up 1.5% to $28.19 at 11:55 a.m. in New York. -Past lawsuits- Bloomberg News reported last month that Sanofi agreed to pay more than $100 million to resolve about 4,000 Zantac cases.